English HTA OKs AbbVie’s Bispecific Antibody Tepkliny for DLBCL After Initial Refusal

 
• By Francesca Bruce
  
Money and Injection
English HTA decides On AbbVie's subcutaneous bispecific antibody • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography